middle.news

How Vitrafy’s Cryopreservation Breakthroughs Set Stage for FY26 Market Debut

9:01am on Wednesday 30th of July, 2025 AEST Healthcare
Read Story

How Vitrafy’s Cryopreservation Breakthroughs Set Stage for FY26 Market Debut

9:01am on Wednesday 30th of July, 2025 AEST
Key Points
  • Revenue growth in commercial aquaculture solutions
  • Completion of VCU2 device design, entering build phase
  • Bovine trials with Select Sires progressing toward Q1 FY26 results
  • Blood platelet study gains recognition in US military medical journal
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE